311 related articles for article (PubMed ID: 24813595)
1. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial.
Kort DH; Lobo RA
Am J Obstet Gynecol; 2014 Nov; 211(5):487.e1-6. PubMed ID: 24813595
[TBL] [Abstract][Full Text] [Related]
2. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
3. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study.
Wang JG; Anderson RA; Graham GM; Chu MC; Sauer MV; Guarnaccia MM; Lobo RA
Fertil Steril; 2007 Jul; 88(1):240-3. PubMed ID: 17296187
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.
Hajimonfarednejad M; Nimrouzi M; Heydari M; Zarshenas MM; Raee MJ; Jahromi BN
Phytother Res; 2018 Feb; 32(2):276-283. PubMed ID: 29250843
[TBL] [Abstract][Full Text] [Related]
5. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome.
Borzoei A; Rafraf M; Asghari-Jafarabadi M
Asia Pac J Clin Nutr; 2018; 27(3):556-563. PubMed ID: 29737802
[TBL] [Abstract][Full Text] [Related]
6. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial.
Eisenhardt S; Schwarzmann N; Henschel V; Germeyer A; von Wolff M; Hamann A; Strowitzki T
J Clin Endocrinol Metab; 2006 Mar; 91(3):946-52. PubMed ID: 16352680
[TBL] [Abstract][Full Text] [Related]
7. The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.
Paoletti AM; Cagnacci A; Depau GF; Orrù M; Ajossa S; Melis GB
Fertil Steril; 1996 Oct; 66(4):527-32. PubMed ID: 8816612
[TBL] [Abstract][Full Text] [Related]
8. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
[TBL] [Abstract][Full Text] [Related]
9. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.
Velázquez E; Acosta A; Mendoza SG
Obstet Gynecol; 1997 Sep; 90(3):392-5. PubMed ID: 9277650
[TBL] [Abstract][Full Text] [Related]
10. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome.
Lucidi RS; Thyer AC; Easton CA; Holden AE; Schenken RS; Brzyski RG
Fertil Steril; 2005 Dec; 84(6):1755-7. PubMed ID: 16359984
[TBL] [Abstract][Full Text] [Related]
11. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
[TBL] [Abstract][Full Text] [Related]
12. Metformin treatment is effective in obese teenage girls with PCOS.
De Leo V; Musacchio MC; Morgante G; Piomboni P; Petraglia F
Hum Reprod; 2006 Sep; 21(9):2252-6. PubMed ID: 16785260
[TBL] [Abstract][Full Text] [Related]
13. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
[TBL] [Abstract][Full Text] [Related]
14. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
15. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
Gerli S; Mignosa M; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2003; 7(6):151-9. PubMed ID: 15206484
[TBL] [Abstract][Full Text] [Related]
16. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
[TBL] [Abstract][Full Text] [Related]
19. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
[TBL] [Abstract][Full Text] [Related]
20. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
